For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)
Por um escritor misterioso
Descrição
Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.
Full article: Investigational drugs for treating agitation in
Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for
JAMA Neurology Publishes Complete Results of Positive Phase 3
FDA Panel Votes in Favor of Brexpiprazole as Potential Therapy for
What medications are used to treat Alzheimer's?
New Alzheimer's Disease Drugs
FDA Approves the First Drug for Alzheimer's Agitation: Rexulti
REXULTI® (brexpiprazole), MDD
FDA approves first drug meant to ease Alzheimer's-linked agitation
REXULTI® (brexpiprazole) Agitation associated with dementia due
REXULTI® (brexpiprazole) agitation that may happen with dementia
Statement on the FDA Approval of Brexpiprazole
de
por adulto (o preço varia de acordo com o tamanho do grupo)
